FASTER, PLEASE: UPMC Leads Global Effort to Fast Track Testing of Hydroxychloroquine and other COVID-19 Therapies with ‘Learning While Doing’ Clinical Trial. “REMAP (randomized, embedded, multi-factorial, adaptive platform) allows researchers to rapidly test multiple treatment approaches simultaneously at a lower cost and with fewer patients than traditional clinical trials.”
InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.